Abstract BACKGROUND Asthma is a heterogeneous disease; therefore, biomarkers that can assist in the identification of subtypes and direct therapy are highly desirable. Asthma is a chronic inflammatory disease that leads to changes in the extracellular matrix (ECM) by matrix metalloproteinases (MMPs) degradation causing fragments of type I collagen that is released into circulation. OBJECTIVE […]
A serological biomarker of type I collagen degradation is related to a more severe, high neutrophilic, obese asthma subtype.
April 13, 2022
Asthma Res Pract